Market Value2,137,654,638
Total Holdings49
File Date2024-08-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
EWTX / Edgewise Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
MGNX / MacroGenics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
ARVN / Arvinas, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
KALV / KalVista Pharmaceuticals, Inc.
KRYS / Krystal Biotech, Inc.
ANAB / AnaptysBio, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
GRTSQ / Gritstone bio, Inc.
RVMD / Revolution Medicines, Inc.
ANTX / AN2 Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
NTLA / Intellia Therapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ADVM / Adverum Biotechnologies, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
ERAS / Erasca, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ORIC / ORIC Pharmaceuticals, Inc.
COGT / Cogent Biosciences, Inc.
AVTE / Aerovate Therapeutics, Inc.
MRUS / Merus N.V.
RARE / Ultragenyx Pharmaceutical Inc.
SLNO / Soleno Therapeutics, Inc.
NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant
CGON / CG Oncology, Inc.
PEPG / PepGen Inc.
BLUE / bluebird bio, Inc.
ACRS / Aclaris Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
TYRA / Tyra Biosciences, Inc.
ADVM / Adverum Biotechnologies, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
ALLO / Allogene Therapeutics, Inc.
IMTX / Immatics N.V.
PBYI / Puma Biotechnology, Inc.
MGX / Metagenomi, Inc.
ETNB / 89bio, Inc.
IRON / Disc Medicine, Inc.
APLT / Applied Therapeutics, Inc.
AGIO / Agios Pharmaceuticals, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
RCKT / Rocket Pharmaceuticals, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
TARS / Tarsus Pharmaceuticals, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
TRVI / Trevi Therapeutics, Inc.
SVRA / Savara Inc.
ELEV / Elevation Oncology, Inc.
BBIO / BridgeBio Pharma, Inc.
HLVX / HilleVax, Inc.